MKVBX
Price
$18.71
Change
-$0.05 (-0.27%)
Updated
Jul 13 closing price
Net Assets
7.31B
TROZX
Price
$26.51
Change
-$0.26 (-0.97%)
Updated
Jul 13 closing price
Net Assets
16.95B
Interact to see
Advertisement

MKVBX vs TROZX

MKVBX vs TROZX Comparison Chart in %
View a ticker or compare two or three
VS
MKVBX vs. TROZX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKVBX is a StrongBuy and TROZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TROZX has more cash in the bank: 17B vs. MKVBX (7.31B). MKVBX pays higher dividends than TROZX: MKVBX (3.10) vs TROZX (2.95). MKVBX was incepted earlier than TROZX: MKVBX (6 years) vs TROZX (6 years). MKVBX (0.99) is less costly to investors than TROZX (0.65). MKVBX is a more actively managed with annual turnover of: 22.00 vs. TROZX (15.00). TROZX has a lower initial minimum investment than MKVBX: TROZX (0) vs MKVBX (1000). TROZX annual gain was more profitable for investors over the last year : 29.33 vs. MKVBX (21.73). TROZX return over 5 years is better than : 100.86 vs. MKVBX (58.35).
MKVBXTROZXMKVBX / TROZX
Total Expense Ratio0.960.00-
Annual Report Gross Expense Ratio0.990.65152%
Fund Existence6 years6 years-
Gain YTD11.80013.33688%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.31B17B43%
Annual Yield % from dividends3.102.95105%
Returns for 1 year21.7329.3374%
Returns for 3 years55.4587.6963%
Returns for 5 years58.35100.8658%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANVIX30.72N/A
N/A
Virtus NFJ Large-Cap Value Fund Inst
BDHAX9.08N/A
N/A
BlackRock Dynamic High Income Inv A
PAGHX143.05N/A
N/A
Permanent Portfolio Aggressive Growth C
UPAAX23.06N/A
N/A
Upright Assets Allocation Plus
JAGLX87.72-0.68
-0.77%
Janus Henderson Global Life Sciences T